Strategic Market Access
Bethesda, United States
Dr. Sarah Ronnebaum is a Scientist in Strategic Market Access, located in Pharmerit’s Bethesda, Maryland office. Her expertise includes systematic and targeted literature reviews, value messaging, and dossiers. Sarah has therapeutic experience in the following areas: cardiovascular disease, oncology, diabetes, aging, infectious disease, addiction, neurological disorders, muscular disorders, and various rare diseases.
Prior to joining Pharmerit, Sarah worked within Deloitte Consulting in Arlington, Virginia across a breadth of roles including strategic planning and implementation for major federal health agencies. Additionally, Sarah served and led projects in the Translational Medicine Group at Deloitte. Sarah was also a postdoctoral fellow and research associate at the University of North Carolina, where she published 7 articles on protein homeostasis mechanisms in major journals. Sarah earned a BS in Pharmaceutical Sciences and a BA in biology from Drake University, then earned a PhD in Pharmacology from Duke University.